Polymerase theta inhibition synergizes with anti-PD-1 immunotherapy in BRCA2-deficient pancreatic ductal adenocarcinoma.

被引：0
|
作者：
Patterson-Fortin, Jeffrey [1 ]
Jadhav, Heta [1 ]
Pantelidou, Constantia [2 ]
Phan, Tin [1 ]
Grochala, Carter [1 ]
Hao, Jie [1 ]
Wang, Junning [1 ]
Andrews, Elizabeth A. [1 ]
Guerriero, Jennifer L. [3 ]
Wolpin, Brian M. [1 ]
Stanger, Ben Z. [4 ]
Aguirre, Andrew A. [1 ]
Cleary, James M. [1 ]
D'Andrea, Alan A. [1 ]
Shapiro, Geoffrey I. [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Bayer US LLC, Pharmaceut, Boston, MA USA
[3] Brigham & Womens Hosp, Dept Surg, Div Breast Surg, 75 Francis St, Boston, MA 02115 USA
[4] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C010
引用
收藏
页码：117 / 118
页数：2
相关论文
共 50 条
  • [1] β-hydroxy-β-methylbutyrate enhances anti-PD1 immunotherapy in a mouse model of pancreatic ductal adenocarcinoma.
    Etigunta, Suhas K.
    Coleman, Michael F.
    Pfeil, Alex J.
    Lashinger, Laura M.
    Cui, Zhengrong
    Hursting, Stephen D.
    CANCER RESEARCH, 2021, 81 (13)
  • [2] BLZ945 and anti-PD-1 combination immunotherapy modulates the immune landscape in pancreatic ductal adenocarcinoma
    Sievers, Chelsie K.
    Emmerich, Philip B.
    Rainiero, Hanna R.
    Maloney, Connor
    Pitera, Rosabella
    Pasch, Cheri A.
    Clipson, Linda
    Matkowskyj, Kristina A.
    Asimakopoulos, Fotis
    Deming, Dustin A.
    CANCER RESEARCH, 2019, 79 (13)
  • [3] PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti-PD-1 Immunotherapy
    Zheng, Yimin
    Wang, Yining
    Lu, Zhou
    Wan, Jinkai
    Jiang, Lulu
    Song, Danjun
    Wei, Chuanyuan
    Gao, Chao
    Shi, Guoming
    Zhou, Jian
    Fan, Jia
    Ke, Aiwu
    Zhou, Lu
    Cai, Jiabin
    ADVANCED SCIENCE, 2023, 10 (29)
  • [4] Glutamate Modulation Synergizes With Anti-PD-1 Immunotherapy in Glioblastoma
    Medikonda, Ravi
    Choi, John
    Pant, Ayush
    Saleh, Laura
    Routkevitch, Denis
    Tong, Luqing
    Belcaid, Zineb
    Kim, Young H.
    Jackson, Christopher M.
    Mathios, Dimitrios
    Shah, Pavan P.
    Lim, Michael
    NEUROSURGERY, 2020, 67 : 294 - 294
  • [5] Polymerase theta synthetic lethal interaction in homologous recombination-deficient pancreatic ductal adenocarcinoma
    Wang, Annie
    Zamperone, Andrea
    Sohail, Mohammad
    Wang, Lidong
    Balogun, Fiyinfolu
    Li, Jiufeng
    Zhao, Ende
    Diolaiti, Daniel
    Sfeir, Agnel
    Simeone, Diane M.
    CANCER RESEARCH, 2019, 79 (24)
  • [6] DDR2 inhibition enhances response to anti-PD-1 immunotherapy
    Tu, Megan M.
    Lee, Francis Y.
    Jones, Robert T.
    Kimball, Abigail K.
    Saravia, Elizabeth
    Graziano, Robert F.
    Coleman, Brianne
    Menard, Krista
    Yan, Jun
    Michaud, Erin
    Chang, Han
    Abdel-Hafiz, Hany A.
    Rozhok, Andrii I.
    Duex, Jason E.
    Agarwal, Neeraj
    Chauca-Diaz, Ana
    Johnson, Linda K.
    Ng, Terry L.
    Cambier, John C.
    Clambey, Eric T.
    Costello, James C.
    Korman, Alan J.
    Theodorescu, Dan
    CANCER RESEARCH, 2019, 79 (13)
  • [7] Polymerase theta inhibition activates the cGAS-STING signaling pathway and elicits an immune response in homologous recombination-deficient pancreatic adenocarcinoma.
    Oh, Grace
    Wang, Annie
    Wang, Lidong
    Li, Jiufeng
    Werba, Gregor
    Weissinger, Daniel
    Zhao, Ende
    Dhara, Surajit
    Hernandez, Rosmel
    Ackermann, Amanda
    Kalfakakou, Despoina
    Kawaler, Emily A.
    Golan, Talia
    Welling, Theodore H.
    Sfeir, Agnel
    Simeone, Diane M.
    CANCER RESEARCH, 2022, 82 (22) : 102 - 102
  • [8] A new vulnerability to BET inhibition due to enhanced autophagy in BRCA2-deficient pancreatic cancer
    Archasappawat, Suyakarn
    Lee, EunJung
    Ji, Keely
    Pena, Jocelyn
    Fernandez-Vega, Virneliz
    Gangaraju, Ritika
    Beesabathuni, Nitin Sai
    Kim, Martin Jean
    Tian, Qi
    Shah, Priya
    Scampavia, Louis
    Spicer, Timothy
    Hwang, Chang-Il
    CANCER RESEARCH, 2024, 84 (02)
  • [9] Evaluation of PARP inhibition as a platinum sparing strategy in Brca2-deficient pancreatic tumors.
    Lowery, Maeve Aine
    Lee, Alycia
    Tobias, Ethan
    Sung, Patricia
    Bhanot, Umeshkumar
    Shakya, Reena
    Ludwig, Thomas
    O'Reilly, Eileen Mary
    Jasin, Maria
    Moynahan, Mary Ellen
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Restored CD8+PD-1+ T Cells Facilitate the Response to Anti-PD-1 for Patients With Pancreatic Ductal Adenocarcinoma
    Zhu, Qian
    Qiao, Guoliang
    Huang, Lefu
    Xu, Chang
    Guo, Deliang
    Wang, Shuo
    Zhao, Jing
    Song, Yuguang
    Liu, Bing
    Chen, Zheng
    Yang, Zhiyong
    Yuan, Yufeng
    FRONTIERS IN ONCOLOGY, 2022, 12
12345